Citius Oncology, Inc. (CTOR)
1.13
-0.03
(-2.59%)
USD |
NASDAQ |
Dec 10, 16:00
1.13
0.00 (0.00%)
After-Hours: 07:47
Citius Oncology Shareholders Equity (Quarterly): 32.40M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | 65.06M |
| Amicus Therapeutics, Inc. | 230.42M |
| Soligenix, Inc. | 7.598M |
| Tonix Pharmaceuticals Holding Corp. | 231.14M |
| GT Biopharma, Inc. | 3.00M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 91.71M |
| Total Liabilities (Quarterly) | 59.31M |
| Debt to Equity Ratio | 0.1173 |
| Current Ratio | 0.3455 |
| Net Debt Paydown Yield | -0.15% |